Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis
Hongxue Shi, Xiaobo Wang, Fang Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 672
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The role of efferocytosis‐fueled macrophage metabolism in the resolution of inflammation
Maaike Schilperoort, David Ngai, Santosh R. Sukka, et al.
Immunological Reviews (2023) Vol. 319, Iss. 1, pp. 65-80
Closed Access | Times Cited: 50
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 35
Efferocytosis in atherosclerosis
Shaunak Adkar, Nicholas J. Leeper
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 762-779
Closed Access | Times Cited: 28
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
Hanren Dai, Cheng Zhu, Qian Huai, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 913-927
Closed Access | Times Cited: 22
Treatment of liver fibrosis: Past, current, and future
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 6, pp. 755-774
Open Access | Times Cited: 39
Mechanical stiffness promotes skin fibrosis via Piezo1-Wnt2/Wnt11-CCL24 positive feedback loop
Jiahao He, Xinwei Cheng, Bin Fang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Dechun Feng, Seonghwan Hwang, Adrien Guillot, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101352-101352
Open Access | Times Cited: 8
MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis
Wen Yu, Shu Wang, Yangyang Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Intracellular Magnetic Hyperthermia Enables Concurrent Down-Regulation of CD47 and SIRPα To Potentiate Antitumor Immunity
Siyao Wang, Wangbo Jiao, Bin Yan, et al.
Nano Letters (2024) Vol. 24, Iss. 9, pp. 2894-2903
Closed Access | Times Cited: 7
Spatial genomics: mapping human steatotic liver disease
Kylie P. Matchett, J Paris, Sarah A. Teichmann, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 9, pp. 646-660
Closed Access | Times Cited: 6
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
Marlene Kohlhepp, Hanyang Liu, Frank Tacke, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 14
Programmed Cell Death in Liver Fibrosis
Ruoyu Gao, Haiying Tang, Jingwei Mao
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 3897-3910
Open Access | Times Cited: 14
Nanosystem Delivers Senescence Activators and Immunomodulators to Combat Liver Cancer
Ke Gong, Juyang Jiao, Zhihua Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 20
Open Access | Times Cited: 5
Cell Death in Liver Disease and Liver Surgery
Christian Stoess, Yeon‐Kyung Choi, Janset Onyuru, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 559-559
Open Access | Times Cited: 4
NLRP3 inflammasome constrains liver regeneration through impairing MerTK-mediated macrophage efferocytosis
Susu Wei, Ge Guan, Xiaoyu Luan, et al.
Science Advances (2025) Vol. 11, Iss. 1
Closed Access
SLC7A11 transporter maintains critical nonessential amino acids levels to hamper ferroptosis during MASLD progression
Elia Casirati, Luca Valenti
Science Bulletin (2025)
Closed Access
Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
Lihui Zhang, Sutong Liu, Qing Zhao, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 2
Closed Access
Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure
Seohyun Kim, Yoon Kyoung Kim, Seonghyun Kim, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Fanglin Ma, Miriam Longo, Marica Meroni, et al.
Cell Metabolism (2025)
Closed Access
SIRPα modulates microglial efferocytosis and neuroinflammation following experimental subarachnoid hemorrhage via the SHP1/STAT6 axis
Bingtao Zhang, Yan Zou, Qikai Tang, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Myeloid cell path to malignancy: insights into liver cancer
Christel Ramirez, Leila Akkari
Trends in cancer (2025)
Open Access
Vitamin B2 enables regulation of fasting glucose availability
Peter M. Masschelin, Pradip K. Saha, Scott A. Ochsner, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 11
Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis
Mengli Yan, Hui Li, Shiyu Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11313-11313
Open Access | Times Cited: 10
Efferocytosis in liver disease
Hongxue Shi, Mary P. Moore, Xiaobo Wang, et al.
JHEP Reports (2023) Vol. 6, Iss. 1, pp. 100960-100960
Open Access | Times Cited: 10
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis
Yingying Liu, Lin Wang
eGastroenterology (2024) Vol. 2, Iss. 1, pp. e100040-e100040
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top